Marcus Capital’s Halozyme HALO Stock Holding History

Marcus Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,825	Closed	-$183K	–	45
2018 Q2	$183K	Sell	10,825 -2,000	-16%	-$37.8K	0.58%	43
2018 Q1	$251K	Sell	12,825 -1,875	-13%	-$36.3K	0.92%	34
2017 Q4	$298K	Buy	+14,700	New	+$270K	1.14%	35

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Marcus Capital's HALO Position: Q3 2018 in Review

Marcus Capital sold out of Halozyme (HALO) in Q3 2018, closing a stake of 10,825 shares — an estimated $183K sold.

Marcus Capital first reported a position in HALO in Q4 2017 and held it in 3 quarters. The position peaked at $298K in Q4 2017. 193 funds tracked by Wall St. Rank hold HALO as of Q3 2018.

Marcus Capital reported no remaining Halozyme position as of Q3 2018 after selling out during the quarter.
Marcus Capital sold 10,825 Halozyme shares in Q3 2018, an estimated $183K.
Marcus Capital first reported a position in Halozyme in Q4 2017 and held it in 3 quarters.
Marcus Capital's Halozyme position peaked at $298K in Q4 2017.
193 funds tracked by Wall St. Rank held Halozyme as of Q3 2018.

Based on Marcus Capital's 13F filing for Q3 2018, filed 13 Nov 2018.